Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.

ABSTRACT:

SUBMITTER: Philippen L 

PROVIDER: S-EPMC10781631 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature